The legend for Figure 4 was incorrect. It is corrected here.
(A) The upper panel shows the schema of MgcRacGAP KR mutants. The lower panel shows the result of Western blotting of 293T cells co-transfected with mock or WT or deletion mutants (ΔGAP, Δ537-632) or KR(K632R, R6) mutants of MgcRacGAP-Flag, together with pcDNA3 (-) or pcDNA3 Myc-CDH1 (+). (B) The left panel shows the schema of fusion proteins between mVenusNLS and full-length or partial fragments of the CT region of MgcRacGAP. The right panel shows the result of FACS analysis of 293T cells co-transfected with each fusion protein, together with pcDNA3 or Myc-CDH1. Inhibition rate is calculated by the ratio of (the % of mVenus (+) cells in CDH1 transfectants)/ (the % of mVenus (+) cells in mock transfectants). The results shown are the means of three independent experiments, and the error bars indicate the standard deviation of the mean (* P <0.01). (C) 293T cells co-transfected with mock or WT or the deletion mutants (Δ537-632, Δ537-570, Δ537-570-ΔDbox) of MgcRacGAP-Flag, together with pcDNA3 (-) or pcDNA3-Myc-CDH1 (+). Relative band intensities of MgcRacGAP were calculated by densitometry analysis and normalized to α-Tubulin.
Citation: The PLOS ONE Staff (2014) Correction: APCCDH1 Targets MgcRacGAP for Destruction in the Late M Phase. PLoS ONE 9(3): e89706. doi:10.1371/journal.pone.0089706
Published: March 5, 2014
Copyright: © 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.